Department of Health and Human Services September 10, 2014 – Federal Register Recent Federal Regulation Documents
Results 1 - 15 of 15
National Advisory Committee on Rural Health and Human Services; Notice of Meeting
HRSA published a notice in the Federal Register, FR 2014-18735 (August 8, 2014), announcing the meeting of the National Advisory Committee on Rural Health and Human Services in Sioux Falls, South Dakota (Federal Register, Vol. 79, No. 153, 46445). The site for the opening of the meeting has been changed.
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Testing Communications on Biological Products
The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Testing Communications on Biological Products'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Health and Diet Survey
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Revocation of General Safety Test Regulations That Are Duplicative of Requirements in Biologics License Applications; Correction
The Food and Drug Administration is correcting a proposed rule entitled ``Revocation of General Safety Test Regulations That Are Duplicative of Requirements in Biological License Applications'' that appeared in the Federal Register of August, 22, 2014. The document proposed to amend the biologics regulations by removing the general safety test requirements for biological products. The document published with the incorrect title. This document corrects that error.
Unique Device Identification System: Small Entity Compliance Guide; Guidance for Industry; Availability
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled ``Unique Device Identification System: Small Entity Compliance Guide'' for a final rule published in the Federal Register of September 2013. This small entity compliance guide (SECG) intends to provide, in plain language, the requirements of the regulation and to help small businesses understand and comply with the regulation.
Medical Devices; Immunology and Microbiology Devices; Classification of Dengue Virus Nucleic Acid Amplification Test Reagents
The Food and Drug Administration (FDA) is classifying dengue virus nucleic acid amplification test reagents into class II (special controls). The Agency is classifying the device into class II (special controls) because special controls, in addition to general controls, will provide a reasonable assurance of safety and effectiveness of the device.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
